Government-bond yields went on a tear following Trump's win on expectations that the president-elect's immigration and ...

The Trump trade was largely extended on Monday, with shares of Tesla, bitcoin, the US dollar, and US bank stocks all surging.

Tesla short-sellers lost $7.8 billion after a 38% post-election surge in shares of the EV maker. Tesla was a popular "Trump ...

In a report released today, Annabel Samimy from Stifel Nicolaus maintained a Hold rating on Revance Therapeutics (RVNC – Research ...

Ed Yardeni said Trump's win bolsters the his thesis of a "Roaring 20s" for stocks. He also upped his 2024 S&P 500 price ...

Analyst Carter Gould of Barclays maintained a Buy rating on AbbVie (ABBV – Research Report), retaining the price target of $212.00.

Shares of AbbVie (ABBV) are sliding on Monday after the company’s drug candidate for schizophrenia failed to meet the key goal in two ...

Truist analyst Srikripa Devarakonda notes that AbbVie (ABBV) announced negative trial results for emraclidine in dual Phase 2 schizophrenia ...

Edgewater Research contended in a note to investors earlier this morning that performance issues with Monolithic Power’s (MPWR) voltage regulator module/Power Management IC “appear likely to severely ...

Deutsche Bank says a sell-side report was issued earlier today that indicated Monolithic Power (MPWR) would lose most if not all of its market ...

Unusual total active option classes on open include: Wendy’s ( WEN ), Novavax ( NVAX ), Payoneer Global ( PAYO ), Luminar Technologies ( LAZR ), Bloom Energy ( BE ), Archer Aviation ( ACHR ), SPDR S&P ...

Stifel Nicolaus analyst Daniel Arias downgraded the rating on Tempus AI, Inc. Class A (TEM – Research Report) to a Hold yesterday, ...